MTD Mettler Toledo
Intrinsic value$568.53
Price (at call)$1,378.69
Margin of safety
-58.8%
vs market (rating basis)
-8.7%
Model unavailable; showing baseline valuation.
⚠ LLM error: empty response; using baseline
The story
Value drivers
| Revenue growth (Y1) | 3.0% |
| Terminal growth | 3.5% |
| Forecast horizon | 10y |
| Target operating margin | 28.2% |
| Years to target margin | 5 |
| Sales-to-capital | 1.94 |
| Beta | 1.22 |
| Failure probability | 0.0% |
| Cost of capital (WACC) | 10.1% |
| Terminal WACC | 9.2% |
Valuation bridge
| PV of explicit FCFF | 6.40B |
| PV of terminal value | 7.08B |
| Equity value | 11.39B |
| ÷ shares → per share | $568.53 |
News
neutral -0.10 · 8 articles
- What Makes Mettler-Toledo International (MTD) an Attractive Bet?
- 2 Profitable Stocks with Competitive Advantages and 1 Facing Headwinds
- Is Mettler-Toledo Stock Underperforming the Nasdaq?
- Research Tools & Consumables Stocks Q2 Teardown: Mettler-Toledo (NYSE:MTD) Vs The Rest
- Redburn starts Mettler-Toledo at Sell, sees valuation outpacing growth
- Do Wall Street Analysts Like Mettler-Toledo Stock?
- Mettler-Toledo (MTD) Upgraded to Buy: Here's Why
- 1 Healthcare Stock to Target This Week and 2 Facing Headwinds
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 4.26B | 3.0% | 28.2% | 995.81M | 63.86M | 931.95M | 846.25M |
| 2 | 4.39B | 3.1% | 28.2% | 1.03B | 66.99M | 959.25M | 790.94M |
| 3 | 4.52B | 3.1% | 28.2% | 1.06B | 70.29M | 987.87M | 739.64M |
| 4 | 4.67B | 3.2% | 28.2% | 1.09B | 73.77M | 1.02B | 692.04M |
| 5 | 4.82B | 3.2% | 28.2% | 1.13B | 77.44M | 1.05B | 647.85M |
| 6 | 4.98B | 3.3% | 28.2% | 1.16B | 81.32M | 1.08B | 606.81M |
| 7 | 5.14B | 3.3% | 28.2% | 1.20B | 85.41M | 1.12B | 568.67M |
| 8 | 5.32B | 3.4% | 28.2% | 1.24B | 89.72M | 1.15B | 533.22M |
| 9 | 5.50B | 3.4% | 28.2% | 1.29B | 94.29M | 1.19B | 500.25M |
| 10 | 5.69B | 3.5% | 28.2% | 1.33B | 99.11M | 1.23B | 469.56M |